mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.093 |
0.08 |
mRNA |
avrainvillamide |
CTRPv2 |
pan-cancer |
AAC |
-0.074 |
0.08 |
mRNA |
UNC0638 |
GDSC1000 |
pan-cancer |
AAC |
0.053 |
0.08 |
mRNA |
(5Z)-7-Oxozeaenol |
GDSC1000 |
pan-cancer |
AAC |
0.055 |
0.08 |
mRNA |
Repligen 136 |
CTRPv2 |
pan-cancer |
AAC |
-0.065 |
0.08 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.064 |
0.08 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.063 |
0.09 |
mRNA |
BRD-K34222889 |
CTRPv2 |
pan-cancer |
AAC |
-0.055 |
0.09 |
mRNA |
ML162 |
CTRPv2 |
pan-cancer |
AAC |
-0.06 |
0.09 |
mRNA |
Doxorubicin |
GDSC1000 |
pan-cancer |
AAC |
0.062 |
0.09 |